Drug recall · October 19, 2016
Moxifloxacin 1 mg/mL in Sterile Balanced Salt Solution recall
Why: Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Moxifloxacin 1 mg/mL in Sterile Balanced Salt Solution (BSS) Intravitreal Injection, 1 mL Total Volume in a 2 mL Vial, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-003-35
- Lots / codes
All unexpired lots; Expirations dates of 09/21/2016 to 2/2/2017
- Quantity
- 76,315 total units, all products
- Company
- Leiter's Compounding, San Jose, CA
- Distribution
- Nationwide
- Initiated
- September 20, 2016 · Voluntary: Firm initiated
- Classified
- October 12, 2016
- Reported
- October 19, 2016
- Ended
- May 3, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Moxifloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.